Biotechnology U.S. doctors plan to treat cancer patients using CRISPR Gene-edited immune cells could help wipe out deadly tumors. by Emily Mullin 2018-01-17T16:39:00-05:00
Biotechnology Gene therapy could make cancer care more unequal, and this map shows why Revolutionary new cancer treatments won’t be available in many rural areas of the U.S. by Emily Mullin 2018-01-12T13:57:00-05:00
Biotechnology Genetic Programmers Are the Next Startup Millionaires The big-ticket acquisition of genetic design company Cell Design Labs signals a coming wave of precision cures. by Antonio Regalado 2017-12-07T18:04:00-05:00
Rewriting Life Patient Death Won’t Slow Research on “Off-the-Shelf” Immune Cells to Treat Cancer The approach could treat patients in dire need faster at a lower price, but questions remain about safety. by Emily Mullin 2017-09-08T13:33:00-04:00
Biotechnology FDA Approves Groundbreaking Gene Therapy for Cancer The treatment will be sold by Novartis for $475,000. by Emily Mullin 2017-08-30T13:54:00-04:00
Rewriting Life This Lab-in-a-Box Could Make Gene Therapy Less Elitist Genetic repairs are curing patients—but only at a few elite centers. by Antonio Regalado 2017-03-08T00:00:00-05:00
Biotechnology Two Infants Treated with Universal Immune Cells Have Their Cancer Vanish In a medical first, the children were treated with genetically engineered T-cells from another person. by Antonio Regalado 2017-01-25T16:25:00-05:00
Rewriting Life A Cure for a Childhood Cancer—but Will It Last? Modifying a child’s immune system to fight off leukemia can yield dramatic results, but the treatments are dangerous and no one knows if they’re permanent. by Michael Reilly 2016-10-05T19:08:00-04:00
